ter Steege EJ, Boer M, Timmer NC, Ammerlaan CM, Song J, Derksen PW, Hilkens J, Bakker ER. R‐spondin‐3 is an oncogenic driver of poorly differentiated invasive breast cancer. The Journal of Pathology. 2022 Sep 15;258(3):289–99. doi: 10.1002/path.5999.